Unknown

Dataset Information

New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors.


ABSTRACT: A series of trifluoromethyl, benzothiazolyl or thiazolyl ketone-containing peptidic compounds as SARS-CoV 3CL protease inhibitors were developed and their potency was evaluated by in vitro protease inhibitory assays. Three candidates had encouraging results for the development of new anti-SARS compounds.

SUBMITTER: Regnier T 

PROVIDER: S-EPMC4436079 | biostudies-literature | 2009 May

REPOSITORIES: biostudies-literature